At close: December 20 at 5:29:41 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-26,341.0000
-25,021.0000
-32,534.0000
16,701.0000
-33,200.0000
Investing Cash Flow
-73,265.0000
-19,982.0000
-113,808.0000
-49,458.0000
57,606.0000
Financing Cash Flow
-1,065.0000
-803.0000
235,022.0000
-714.0000
-669.0000
End Cash Position
29,321.0000
85,272.0000
131,078.0000
42,398.0000
75,869.0000
Issuance of Capital Stock
--
--
254,911.0000
--
--
Free Cash Flow
-26,341.0000
-25,021.0000
-32,534.0000
16,701.0000
-33,200.0000
12/31/2020 - 4/15/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIPUM.ST Lipum AB (publ)
12.90
0.00%
MODTX.ST Modus Therapeutics Holding AB (publ)
1.9000
-4.76%
ALTE.ST Alteco Medical AB
0.2280
+15.15%
ABERA.ST Abera Bioscience AB
4.1500
+3.75%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1378
-13.77%
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
CRNA.OL Circio Holding ASA
0.7080
-3.28%
FLUI.ST Fluicell AB (publ)
0.0412
-1.90%
ATORX.ST Alligator Bioscience AB (publ)
0.2665
+3.50%